Generation of candidate human influenza vaccine strains in cell culture – rehearsing the European response to an H7N1 pandemic threat
Alison Whiteley(University of Reading), William Barclay(Imperial Valley College), Maria Zambon(Public Health England), Isabelle Legastelois(Sanofi (France)), John Wood(Women's and Children's Hospital), Diane Major(National Institute for Biological Standards and Control), Isabella Donatelli(Istituto Superiore di Sanità), Catherine Thompson(Public Health England), Laura Campitelli(Istituto Superiore di Sanità)
Cited by 29
Related Papers
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
|The Lancet|2003|1.1k
The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
|Nature Microbiology|2021|802
The origins of SARS-CoV-2: A critical review
|Cell|2021|511
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
|Journal of Clinical Investigation|2008|349